Zosano Pharma ZSAN shares are trading higher after the company announced publication of clinical data regarding the long-term use of Qtrypta for the treatment of acute migraine in The Journal of Headache and Pain.
Zosano Pharma is currently up 17.59% to a price of $0.87. The stock's volume is currently 17.54 million, which is roughly 925.16% of its recent 30-day volume average of 1.90 million.
The stock's 50-day moving average was $1.0 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $3.06 and fallen to a low of $0.33.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
